Article
Cdc20 hypomorphic mice fail to counteract de novo synthesis of cyclin B1 in mitosis.
The Journal of cell biology - 18 Oct 2010
Malureanu Liviu, Jeganathan Karthik B, Jin Fang, Baker Darren J, van Ree Janine H, Gullon Oliver, Chen Zheyan, Henley John R, van Deursen Jan M
Abstract excerpt
Cdc20 is an activator of the anaphase-promoting complex/cyclosome that initiates anaphase onset by ordering the destruction of cyclin B1 and securin in metaphase. To study the physiological significance of Cdc20 in higher eukaryotes, we generated hypomorphic mice that express small amounts of this essential cell cycle regulator. In this study, we show that these mice are healthy and not prone to cancer despite...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
